SciClone Pharmaceuticals, Inc. (SCLN) Reports Anticipated Financial Results for the First Quarter 2013
5/17/2013 10:45:20 AM
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) Reaches Neucardin Deal for Up to $40.5 Million With Zensun
5/17/2013 7:15:33 AM
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) Appoints PricewaterhouseCoopers LLP as Its Independent Registered Public Accounting Firm
4/8/2013 9:23:51 AM
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) Reports 2012 Financial Results and 2013 Outlook
4/2/2013 9:22:13 AM
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) to Report 2012 Financial Results and 2013 Outlook on April 1st
4/1/2013 8:53:14 AM
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) Appoints Hong Zhao as CEO
3/22/2013 7:19:46 AM
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) Provides Update on the Timing of Filing Its 2012 Annual Report on Form 10-K
3/15/2013 9:40:43 AM
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) to Restate Financial Statements for 2012 and 2011 Periods
2/25/2013 9:53:17 AM
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) to Present at Biotechnology Industry Organization (BIO) CEO & Investor Conference on February 12th
2/5/2013 10:25:13 AM
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) Announces Product Promotion Agreement Renewal With Key Industry Partner Sanofi (France) (SAN.PA) in China
1/31/2013 9:21:43 AM
More...
|
|